TITLE

FDA: Apple's iPods Safe With Pacemakers

PUB. DATE
February 2008
SOURCE
Red Herring;2/1/2008, p2
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article discusses research which found that portable media players such as iPods are unlikely to interfere with heart pacemakers. It references a study by U.S. Food and Drug Administration (FDA) researcher Howard Bassen and colleagues which appeared in the journal "BioMedical Engineering OnLine." Bassen tested a variety of iPods to determine if they can produce enough amount of electromagnetic field that can interfere with the devices. The experiment has revealed that iPods could not affect cardiac pacemakers.
ACCESSION #
36876289

 

Related Articles

  • Panel: Revo, MRI compatible: FDA, Medtronic also friendly. MCCARTY, MARK // Medical Device Daily;3/23/2010, Vol. 14 Issue 55, p1 

    The article reports on the approval sought by Medtronic from the circulatory systems advisory committee panel of the U.S. Food and Drug Administration (FDA) for its magnetic resonance imaging (MRI)-compatible pacemaker Revo SureScan. It notes that Medtronic used worst case scenarios in bench...

  • Boston Sci adds FDA approval to recent CE marking for Altrua.  // Medical Device Daily;5/9/2008, Vol. 12 Issue 91, p10 

    This article reports on the claim by Boston Scientific that the U.S. Food and Drug Administration (FDA) has approved its Altrua family of pacemakers after the company won the CE mark for the product line. The company claims that the pacemaker is its most advanced product and deliver enhanced...

  • New pacemaker proves safe, effective for MRI. PEDERSEN, AMANDA // Medical Device Daily;1/19/2011, Vol. 15 Issue 12, p1 

    The article reports on a trial published in the January 2011 issue of "HeartRhythm" which revealed that the Revo pacemaker from Medtronic has been proven safe and effective to use during magnetic resonance imaging (MRI). It reports that the pacemaker has won a U.S. Food Drug Administration (FDA)...

  • St. Jude's new Zephyr pacemakers win U.S., European approvals.  // Cardiovascular Device Update;May2007, Vol. 13 Issue 5, p26 

    The article reports that the Zephyr pacemakers from Saint Jude Medical won approval from the U.S. Food and Drug Administration (FDA) and CE-marking approval in Europe. The pacemaker is designed to save clinic time by automatically performing all follow-up testing before the patient arrives in...

  • FDA study evaluates rising ICD malfunction trend.  // Materials Management in Health Care;Oct2005, Vol. 14 Issue 10, p8 

    Evaluates the implantable cardioverter defibrillators (ICD) malfunction trend in the U.S., by the Food and Drug Administration. Basis in the study of the ICD; Decrease rate replacements due to malfunctions; Citations of the overall malfunctions of ICD and pacemakers.

  • BIOTRONIK Receives FDA Approval for Expansion of the Premium Evia Pacemaker Portfolio.  // Biomedical Market Newsletter;5/28/2011, p436 

    The article reports on the announcement from the manufacturer of implantable cardiac devices, BIOTRONIK USA, that they had received approval from the U.S. Food and Drug Administration (FDA) for the expansion of their premium Evia pacemaker portfolio. It mentions that the product line combined...

  • Patients Alerted to Pacemaker Recall Search Consumer Updates.  // Biomedical Market Newsletter;3/7/2011, p404 

    The article offers information on the alerts made to the patients regarding pacemaker recall. It states that U.S. Food & Drug Administration (FDA) alerted patients to the Class I recall of certain Medtronic Kappa and Sigma pacemakers. It mentions that the recalled devices may fail due to a...

  • Devices That Keep the Heart Beating Search Consumer Updates.  // Biomedical Market Newsletter;3/7/2011, p405 

    The article offers information on different types of heart devices and approval of the U.S. Food & Drug Administration (FDA). It states that heart devices such as pacemakers and defibrillators have extended and improved the lives of millions of people worldwide. It mentions that FDA has new type...

  • Product briefs.  // Biomedical Business & Technology;Jun2008, Vol. 31 Issue 6, p38 

    The article reports that Boston Scientific received an approval from the U.S. Food and Drug Administration for its Altrua pacemakers. The company claims Altrua is its most advanced pacemaker. It adds that it is the first pacemaker to treat bradycardia. Some of the features of Altrua include...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics